Newsroom

LAS VEGAS--(BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”) today celebrated the official grand opening of Caesars Race & Sportsbook at The Resort at Summerlin, marking the first retail Caesars Sportsbook location in Summerlin and bringing a premium in-person and mobile sports wagering experience to the community. The opening included a ribbon cutting ceremony with Caesars Entertainment and The Resort at Summerlin executives, along with former Vegas Golden Knights defe...

BOSTON--(BUSINESS WIRE)--La 13.ª encuesta global anual a los inversores de ETF (Global ETF Investor Survey) que ha realizado Brown Brothers Harriman (BBH) Investor Services a diversos inversores institucionales, administradores de fondos y asesores financieros, señala que hay un gran entusiasmo por las nuevas estructuras de ETF, incluso cuando los inversores se vuelven a centrar en los fundamentos para generar alfa en el marco de una mayor volatilidad del mercado. Los resultados de este año mue...

BASILEA, Svizzera--(BUSINESS WIRE)--DIA, un'organizzazione globale no-profit di professionisti di scienze della vita, riunirà le parti interessate da tutta Europa e oltre per parlare di come migliorare l'efficienza dei sistemi sanitari, la collaborazione internazionale e i recenti sviluppi nell'innovazione dell'UE dei quadri normativi al DIA Europe 2026 (24–26 marzo, Rotterdam, Paesi Bassi). La principale conferenza europea per diverse parti interessate, DIA Europe riunirà oltre 300 oratori pro...

PEABODY, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--The Progeria Research Foundation (“PRF”), een non-profit onderzoeksorganisatie die zich toelegt op het ontwikkelen van behandelingen en een remedie voor het syndroom van Hutchinson-Gilford (doorgaans aangeduid als “progeria”), en Forge Biologics, (“Forge”), een vooraanstaande fabrikant van gentherapieën en lid van de groep Ajinomoto Bio-Pharma Services, kondigden vandaag een productieovereenkomst aan om de ontwikkeling en productie te ondersteun...

PEABODY, Massachusetts y COLUMBUS, Ohio--(BUSINESS WIRE)--La Fundación para la Investigación de la Progeria (PRF), una organización de investigación sin ánimo de lucro especializada en desarrollar tratamientos y la cura del síndrome de Hutchinson-Gilford (progeria), junto con Forge Biologics ("Forge"), fabricante líder de terapias génicas y miembro del grupo Ajinomoto Bio-Pharma Services, han anunciado hoy que han suscrito un acuerdo de fabricación para promover el desarrollo y la fabricación d...

PEABODY, Mass. e COLUMBUS, Ohio--(BUSINESS WIRE)--La Progeria Research Foundation (“PRF”), un'organizzazione no-profit dedicata alla ricerca per sviluppare terapie e la cura per la sindrome di Hutchinson-Gilford (di seguito, “progeria”), e Forge Biologics, (di seguito, “Forge”), un produttore leader di terapie geniche e membro del gruppo Ajinomoto Bio-Pharma Services, oggi ha annunciato un accordo di produzione a sostegno dello sviluppo e della produzione di SamPro-2, la terapia genica sperimen...

MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a property leased to a national automotive service operator for $1.6 million. The property is located in a highly trafficked corridor in Texas and corporate under a long term, triple net lease with approximat...

PEABODY, Massachusetts et COLUMBUS, Ohio--(BUSINESS WIRE)--La Progeria Research Foundation (« PRF », ou Fondation de recherche sur la progéria), une organisation de recherche à but non lucratif dédiée au développement de traitements et d’un remède contre le syndrome de Hutchinson-Gilford (ou « progéria »), et Forge Biologics (« Forge »), un fabricant de premier plan de thérapies géniques et membre du groupe Ajinomoto Bio-Pharma Services, ont annoncé aujourd’hui la conclusion d’un accord de fabr...

PEABODY, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--The Progeria Research Foundation („PRF“), eine gemeinnützige Forschungsorganisation, die sich der Entwicklung von Behandlungsmethoden und Heilmitteln für das Hutchinson-Gilford-Progerie-Syndrom („Progerie“) widmet, und Forge Biologics („Forge“), ein führender Hersteller von Gentherapien und Mitglied der Ajinomoto Bio-Pharma Services Group, gaben heute eine Produktionsvereinbarung bekannt, um die Entwicklung und Herstellung von SamPro-2 zu unters...

MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) will release its fiscal fourth quarter and full year results through January 3, 2026, before market open on Thursday, March 12, 2026. Management will host its regularly scheduled conference call to discuss the company’s results at 8:30 a.m. EDT (7:30 a.m. CDT; 5:30 a.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at ir.sleepnumber.com. The webcast replay will remain availa...